Stoke Therapeutics
STOK
24.29
-0.08
-0.33%
Stoke Therapeutics
US · STOK
#2942 by market cap
Listed 2019
24.29
-0.08
-0.33%
Live - 5344 symbols - heartbeat 459s ago
· 2026-10-08 07:31
Pre-market
23.50
-3.25%
After-hours
24.29
0.00%
- Market cap
- 1.57B
- P/E (TTM)i
- -7.25
- P/Bi
- 4.54
- EPSi
- -0.12
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on STOK?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
45.11 +85.7%
Price target rangecurrent 24.29
Low35.00
Avg45.11
High60.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-21 | J.P. Morgan | -- | BUY | 40.00 |
| 2026-08-12 | CCORF | -- | BUY | 58.00 |
| 2026-08-04 | TD Cowen | -- | BUY | 60.00 |
| 2026-08-04 | CCORF | -- | BUY | 58.00 |
| 2026-08-04 | Needham | -- | BUY | 40.00 |
| 2026-08-04 | H.C. Wainwright | -- | BUY | 50.00 |
| 2026-08-03 | Chardan Capital | -- | BUY | 35.00 |
| 2026-08-03 | Wolfe Research | -- | BUY | 40.00 |
| 2026-08-03 | BTIG | -- | BUY | 39.00 |
| 2026-08-03 | Goldman Sachs | -- | BUY | 44.00 |
| 2026-07-13 | Goldman Sachs | -- | BUY | 44.00 |
| 2026-07-09 | Needham | -- | BUY | 40.00 |
| 2026-06-02 | Leerink Partners | -- | BUY | -- |
| 2026-05-11 | BTIG | -- | BUY | 39.00 |
| 2026-05-08 | CCORF | -- | BUY | 60.00 |
| 2026-05-08 | Wedbush | -- | BUY | 38.00 |
| 2026-05-08 | Needham | -- | BUY | 40.00 |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 50.00 |
| 2026-05-07 | TD Cowen | -- | BUY | -- |
| 2026-05-07 | Guggenheim | -- | BUY | 60.00 |
| 2026-04-22 | H.C. Wainwright | -- | BUY | 50.00 |
| 2026-04-15 | Needham | -- | BUY | 40.00 |
| 2026-03-20 | CCORF | -- | BUY | 60.00 |
| 2026-03-20 | H.C. Wainwright | -- | BUY | 50.00 |
| 2026-03-18 | BTIG | -- | BUY | 39.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-03 | After close | ±10.11% | +7.14% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±17.54% | +0.31% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±20.89% | -9.94% (in line) |
| 2025/Q2 | 2025-08-12 | After close | -- | +24.98% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:31:22 · For reference only, not investment advice and not tailored to your situation.